Fecal microbiota transplantation with an anaerobic cultivated human intestinal microbiome failed to improve gastrointestinal symptoms in patients with systemic sclerosis, a phase 2 study showed.
Microbiome as a potential key to better treatment: Clinical study on new therapy for Crohn's disease
A special liquid diet, known as exclusive enteral nutrition, is an essential therapy for Crohn's disease. Patients consume only this formula for six to eight weeks, completely avoiding solid foods.
A special liquid diet, known as exclusive enteral nutrition, is an essential therapy for Crohn's disease. Patients consume ...
A special liquid diet, known as exclusive enteral nutrition, is an essential therapy for Crohn's disease. Patients consume ...
For a seamless experience for patients, colonoscopic fecal microbiota transplantation allows for the restoration of gut ...
Phase 2 clinical trial shows a safe dose from a specific donor helped with gut microbiome recovery in people with cancer ...
End-stage liver disease is associated with disruptions in gut microbiota composition and function, which may facilitate ...
The current study is the first in the world to increase our knowledge of how the liver graft preservation method impacts fecal microbiota in the perioperative period of liver transplant patients. A ...
End-stage liver disease is associated with disruptions in gut microbiota composition and function, which may facilitate gut-to-liver bacterial ...
Although gut microbiota and lipid metabolites have been suggested to be closely associated with type 2 diabetes mellitus (T2DM), the interactions between gut microbiota, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback